Keros Therapeutics, Inc.
Clinical trials sponsored by Keros Therapeutics, Inc., explained in plain language.
Keros Therapeutics, Inc.
KROS
NASDAQ
A clinical-stage biopharmaceutical company developing treatments for hematological and musculoskeletal disorders.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.